Submission of new drug application of amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenic syndrome (LEMS) in Japan - DyDo Pharma, Inc.

Submission of new drug application of amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenic syndrome (LEMS) in Japan

What's News December 18, 2023

For details, please see the PDF below.
> Submission of new drug application of amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenic syndrome (LEMS) in Japan（PDF）